Gao Ming, Liu Haokun, Sun Qiying, Yang Guang
Department of Geriatrics, Xiangya Hospital, Central South University, Changsha, China.
Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Front Neurol. 2022 Aug 1;13:874613. doi: 10.3389/fneur.2022.874613. eCollection 2022.
Neurofibromatosis type I (NF1) is an autosomal dominant disease. Some NF1 patients experience atypical clinical manifestations, genetic testing is not widely available, and the types of mutations vary; thus, they are prone to misdiagnosis and missed diagnosis. Although headache is not included in the diagnostic criteria for NF1, the incidence of headache in NF1 patients is not low. We report an NF1 family in which the proband presented with prominent headache and atypical clinical presentation, with limited skin pigmentation. We identified a frameshift mutation (c.1541_1542del, p. Q514Rfs) in the gene by whole-exome sequencing of this family, and the patients were diagnosed with NF1. We hope to attract the attention of clinicians to these patients and improve genetic testing as soon as possible to increase the diagnosis rate.
I型神经纤维瘤病(NF1)是一种常染色体显性疾病。一些NF1患者会出现非典型临床表现,基因检测尚未广泛开展,且突变类型各异;因此,他们容易被误诊和漏诊。虽然头痛并不包含在NF1的诊断标准中,但NF1患者中头痛的发生率并不低。我们报告了一个NF1家系,先证者表现为明显的头痛和非典型临床表现,皮肤色素沉着有限。通过对这个家系进行全外显子测序,我们在该基因中鉴定出一个移码突变(c.1541_1542del,p.Q514Rfs),这些患者被诊断为NF1。我们希望引起临床医生对这些患者的关注,并尽快改进基因检测以提高诊断率。